Komori
EnBio Holdings,Inc (6092) · FactRestated

Application of the Fair Value Measurement Accounting Standards

First written in FY2022-Q2. 1 of 2 entries say "Restated". Latest entry: FY2023-Q2.

2entries
2years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2022-Q2 – FY2023-Q22021: 120212022: 12022
Same theme, other companies
Preparing for the application of the accounting standards for fair value measurementA theme 1848 companies write about · 5 as a headwind · 3 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 196 companies compared. The sentences above are computed from all 196.Comparing 200 of the theme's 1889 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2023-Q2RestatedAnnual report

    「The company applied the Implementation Guidance on Accounting Standard for Fair Value Measurement (ASBJ Guidance No. 31, 17 June 2021; hereinafter, the “Fair Value Measurement Implementation Guidance”) from the beginning of the first quarter of the current consolidated fiscal year. In accordance with the transitional treatment prescribed in paragraph 27-2 of the guidance, it decided to apply the new accounting policies prescribed by the guidance prospectively. There was no impact on the quarterly consolidated financial statements.」

    The company applied the Fair Value Measurement Implementation Guidance from the beginning of the fiscal year and reconfirmed that it had no impact on the financial statements.
  2. FY2022-Q2First statedAnnual report

    「The company applied the Accounting Standard for Fair Value Measurement (ASBJ Statement No. 30, 4 July 2019; hereinafter, the “Fair Value Measurement Standard”) and other standards from the beginning of the first quarter of the current consolidated fiscal year. In accordance with the transitional treatment prescribed in paragraph 19 of the Fair Value Measurement Standard and paragraph 44-2 of the Accounting Standard for Financial Instruments (ASBJ Statement No. 10, 4 July 2019), it decided to apply the new accounting policies prescribed by the Fair Value Measurement Standard and other standards prospectively. This had no impact on the quarterly consolidated financial statements for the cumulative second quarter of the current fiscal year.」

    The company applied the Fair Value Measurement Standard and other standards from the beginning of the fiscal year, disclosing that they had no impact on the quarterly consolidated financial statements for the cumulative second quarter.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for EnBio Holdings,Inc yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.